Discovery Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-234,715
| Closed | -$9.2M | – | 58 |
|
|
2018
Q2 | $9.2M | Buy |
234,715
+35,800
| +18% | +$1.4M | 0.5% | 37 |
|
|
2018
Q1 | $14.4M | Sell |
198,915
-276,260
| -58% | -$20M | 0.5% | 37 |
|
|
2017
Q4 | $31.3M | Sell |
475,175
-307,884
| -39% | -$20.3M | 0.97% | 32 |
|
|
2017
Q3 | $39.2M | Sell |
783,059
-182,000
| -19% | -$9.12M | 0.94% | 35 |
|
|
2017
Q2 | $44.7M | Buy |
965,059
+583,529
| +153% | +$27M | 1.08% | 28 |
|
|
2017
Q1 | $13.5M | Sell |
381,530
-660,516
| -63% | -$23.3M | 0.25% | 72 |
|
|
2016
Q4 | $13M | Sell |
1,042,046
-7,954
| -0.8% | -$99.6K | 0.22% | 76 |
|
|
2016
Q3 | $14.5M | Hold |
1,050,000
| – | – | 0.31% | 55 |
|
|
2016
Q2 | $10.4M | Buy |
1,050,000
+243,895
| +30% | +$2.41M | 0.24% | 57 |
|
|
2016
Q1 | $13.6M | Buy |
806,105
+138,573
| +21% | +$2.34M | 0.2% | 65 |
|
|
2015
Q4 | $14.9M | Buy |
667,532
+143,332
| +27% | +$3.19M | 0.18% | 69 |
|
|
2015
Q3 | $12.4M | Buy |
+524,200
| New | +$12.4M | 0.14% | 85 |
|